Allogeneic Bone Marrow Transplantation from Unrelated Human T-Cell Leukemia Virus-I-negative Donors for Adult T-Cell Leukemia/Lymphoma: Retrospective Analysis of Data from the Japan Marrow Donor Program

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 1, 2007, Pages 90-99

  Kato, Koji ^a,b   Kanda, Yoshinobu ^c   Eto, Tetsuya ^a   Muta, Tsuyoshi ^a   Gondo, Hisashi ^a   Taniguchi, Shuichi ^d   Shibuya, Tsunefumi ^a   Utsunomiya, Atae ^e   Kawase, Takakazu ^f   Kato, Shunichi ^g   Morishima, Yasuo ^f   Kodera, Yoshihisa ^h   Harada, Mine ⁱ  

^a HAMANOMACHI HOSPITAL   (Japan)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d TORANOMON HOSPITAL   (Japan)

^e IMAMURA BUN IN HOSPITAL   (Japan)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

^g TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Allogeneic hematopoietic stem cell transplantation; Graft versus adult T cell leukemia lymphoma; Unrelated donor

Indexed keywords

CYCLOSPORIN; METHOTREXATE; TACROLIMUS;

ADULT; AGE DISTRIBUTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEALTH PROGRAM; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INCIDENCE; JAPAN; LEUKEMIA REMISSION; LIVING DONOR; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; T CELL LEUKEMIA; T CELL LYMPHOMA;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAPAN; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33845975998     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.09.002     Document Type: Article

References (34)

1. Uchiyama T., Yodoi J., Sagawa K., et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50 (1977) 481-492
2. Yoshida M., Miyoshi I., and Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79 (1982) 2031-2035
3. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T- cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79 (1991) 428-437
4. Kuwazuru Y., Hanada S., Furukawa T., et al. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 76 (1990) 2065-2071
5. Ikeda K., Oka M., Yamada Y., et al. Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes. Int J Cancer 82 (1999) 599-604
6. Taguchi H., Kinoshita K.I., Takatsuki K., et al. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 12 (1996) 182-186
7. Yamada Y., Tomonaga M., Fukuda H., et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113 (2001) 375-382
8. Tsukasaki K., Maeda T., Arimura K., et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 23 (1999) 87-89
9. Utsunomiya A., Miyazaki Y., Takatsuka Y., et al. Improved outcome of adult T-cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27 (2001) 15-20
10. Kami M., Hamaki T., Miyakoshi S., et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 120 (2003) 304-309
11. Fukushima T., Miyazaki Y., Honda S., et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 19 (2005) 829-834
12. Momita S., Ikeda S., Amagasaki T., et al. Survey of anti-human T-cell leukemia virus type I antibody in family members of patients with adult T-cell leukemia. Jpn J Cancer Res 81 (1990) 884-889
13. Chen Y.C., Wang C.H., Su I.J., et al. Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood 74 (1989) 388-394
14. Tamaki H., and Matsuoka M. Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med 354 (2006) 1758-1759
15. Ogata M., Ogata Y., Imamura T., et al. Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia. Bone Marrow Transplant 30 (2002) 699-701
16. Ishikawa T. Current status of therapeutic approaches to adult T-cell leukemia. Int J Hematol 78 (2003) 304-311
17. Izutsu K., Kanda Y., Ohno H., et al. Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood 103 (2004) 1955-1960
18. Nakase K., Hara M., Kozuka T., et al. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant 37 (2006) 41-44
19. Terasaki P.I., and McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998-1000
20. Sasazuki T., Juji T., Morishima Y., et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 339 (1998) 1177-1185
21. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18 (1974) 295-304
22. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328 (1993) 593-602
23. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic cutaneous graft-versus-host syndrome on man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
24. Gooley T.A., Leisenring W., Crowley J., et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
25. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
26. Bierman P.J., Molina L., Nelson G., et al. Matched unrelated donor (MUD) allogeneic bone marrow transplantation for Non-Hodgkin's lymphoma (NHL): results from the National Marrow Donor Program (NMDP). [abstract]. Proc Am Soc Clin Oncol 18 (1999) 3a
27. Morishima Y., Kodera Y., Hirabayashi N., et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 15 (1995) 235-239
28. Kodera Y., Morishima Y., Kato S., et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 24 (1999) 995-1003
29. Harashima N., Kurihara K., Utsunomiya A., et al. Graft-versus-tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64 (2004) 391-399
30. Giralt S., Estey E., Albitar M., et al. Engraftment of allogeneic hematopoietic progenitor ccells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89 (1997) 4531-4536
31. Slavin S., Nagler A., Naparstek E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 (1998) 756-763
32. Okamura J., Utsunomiya A., Tanosaki R., et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 105 (2005) 4143-4245
33. Matsushita K., Arima N., Ohtsubo H., et al. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukaemia cells. Br J Haematol 96 (1997) 715-723
34. Imirizaldu J.J., Esteban J.C., Axpe I.R., et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 74 (2003) 1080-1084